急性心不全（AHF）治療薬の世界市場（～2026年）

• 英文タイトル：Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY13562 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は急性心不全（AHF）治療薬のグローバル市場について調査・分析したレポートです。種類別（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性心不全（AHF）治療薬の競争状況、市場シェア ・世界の急性心不全（AHF）治療薬市場：種類別市場規模 2015年-2020年（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他） ・世界の急性心不全（AHF）治療薬市場：種類別市場規模予測 2021年-2026年（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他） ・世界の急性心不全（AHF）治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、在宅ケア） ・世界の急性心不全（AHF）治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、在宅ケア） ・北米の急性心不全（AHF）治療薬市場分析：米国、カナダ ・ヨーロッパの急性心不全（AHF）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性心不全（AHF）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性心不全（AHF）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性心不全（AHF）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Cytokinetics, Inc.、Merck & Co.、Novartis AG、Orion Corporation、PhaseBio Pharmaceuticals, Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market
The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026.

Global Acute Heart Failure (AHF) Therapeutics Scope and Market Size
Acute Heart Failure (AHF) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Heart Failure (AHF) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc

Market segment by Type, the product can be split into
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
Market segment by Application, split into
Hospital
Clinic
Home Care

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Heart Failure (AHF) Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 B-Blockers
1.4.3 Calcium Channel Blockers
1.4.4 Cardiac Glycosides
1.4.5 Diuretics
1.4.6 Morphine
1.4.7 Vasodilators/Nitrates
1.4.8 Others
1.5 Market by Application
1.5.1 Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Acute Heart Failure (AHF) Therapeutics Market Perspective (2015-2026)
2.2 Global Acute Heart Failure (AHF) Therapeutics Growth Trends by Regions
2.2.1 Acute Heart Failure (AHF) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Heart Failure (AHF) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Heart Failure (AHF) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Heart Failure (AHF) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Market Size
3.1.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Heart Failure (AHF) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio
3.2.1 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Heart Failure (AHF) Therapeutics Revenue in 2019
3.3 Acute Heart Failure (AHF) Therapeutics Key Players Head office and Area Served
3.4 Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
3.5 Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)
5.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
6.2 Acute Heart Failure (AHF) Therapeutics Key Players in North America (2019-2020)
6.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
6.4 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
7.2 Acute Heart Failure (AHF) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
8.2 Acute Heart Failure (AHF) Therapeutics Key Players in China (2019-2020)
8.3 China Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
8.4 China Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
9.2 Acute Heart Failure (AHF) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
10.2 Acute Heart Failure (AHF) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
11.2 Acute Heart Failure (AHF) Therapeutics Key Players in India (2019-2020)
11.3 India Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
11.4 India Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
12.2 Acute Heart Failure (AHF) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bayer AG
13.1.1 Bayer AG Company Details
13.1.2 Bayer AG Business Overview
13.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Introduction
13.1.4 Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020))
13.1.5 Bayer AG Recent Development
13.2 Bristol-Myers Squibb Company
13.2.1 Bristol-Myers Squibb Company Company Details
13.2.2 Bristol-Myers Squibb Company Business Overview
13.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Introduction
13.2.4 Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.2.5 Bristol-Myers Squibb Company Recent Development
13.3 Cardiorentis AG
13.3.1 Cardiorentis AG Company Details
13.3.2 Cardiorentis AG Business Overview
13.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Introduction
13.3.4 Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.3.5 Cardiorentis AG Recent Development
13.4 CVie Therapeutics Limited
13.4.1 CVie Therapeutics Limited Company Details
13.4.2 CVie Therapeutics Limited Business Overview
13.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Introduction
13.4.4 CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.4.5 CVie Therapeutics Limited Recent Development
13.5 Cytokinetics, Inc.
13.5.1 Cytokinetics, Inc. Company Details
13.5.2 Cytokinetics, Inc. Business Overview
13.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Introduction
13.5.4 Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.5.5 Cytokinetics, Inc. Recent Development
13.6 Merck & Co.
13.6.1 Merck & Co. Company Details
13.6.2 Merck & Co. Business Overview
13.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Introduction
13.6.4 Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.6.5 Merck & Co. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview
13.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Introduction
13.7.4 Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Orion Corporation
13.8.1 Orion Corporation Company Details
13.8.2 Orion Corporation Business Overview
13.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Introduction
13.8.4 Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.8.5 Orion Corporation Recent Development
13.9 PhaseBio Pharmaceuticals, Inc
13.9.1 PhaseBio Pharmaceuticals, Inc Company Details
13.9.2 PhaseBio Pharmaceuticals, Inc Business Overview
13.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Introduction
13.9.4 PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
13.9.5 PhaseBio Pharmaceuticals, Inc Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Acute Heart Failure (AHF) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Heart Failure (AHF) Therapeutics Revenue
Table 3. Ranking of Global Top Acute Heart Failure (AHF) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of B-Blockers
Table 6. Key Players of Calcium Channel Blockers
Table 7. Key Players of Cardiac Glycosides
Table 8. Key Players of Diuretics
Table 9. Key Players of Morphine
Table 10. Key Players of Vasodilators/Nitrates
Table 11. Key Players of Others
Table 12. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Acute Heart Failure (AHF) Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Acute Heart Failure (AHF) Therapeutics Players
Table 23. Global Acute Heart Failure (AHF) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2019)
Table 26. Global Acute Heart Failure (AHF) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
Table 29. Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Acute Heart Failure (AHF) Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Acute Heart Failure (AHF) Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Acute Heart Failure (AHF) Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 39. North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 41. North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 45. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 51. China Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 53. China Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 57. Japan Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 69. India Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 71. India Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Acute Heart Failure (AHF) Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Acute Heart Failure (AHF) Therapeutics Market Share (2019-2020)
Table 75. Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2015-2020)
Table 79. Bayer AG Company Details
Table 80. Bayer AG Business Overview
Table 81. Bayer AG Product
Table 82. Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 83. Bayer AG Recent Development
Table 84. Bristol-Myers Squibb Company Company Details
Table 85. Bristol-Myers Squibb Company Business Overview
Table 86. Bristol-Myers Squibb Company Product
Table 87. Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 88. Bristol-Myers Squibb Company Recent Development
Table 89. Cardiorentis AG Company Details
Table 90. Cardiorentis AG Business Overview
Table 91. Cardiorentis AG Product
Table 92. Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 93. Cardiorentis AG Recent Development
Table 94. CVie Therapeutics Limited Company Details
Table 95. CVie Therapeutics Limited Business Overview
Table 96. CVie Therapeutics Limited Product
Table 97. CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 98. CVie Therapeutics Limited Recent Development
Table 99. Cytokinetics, Inc. Company Details
Table 100. Cytokinetics, Inc. Business Overview
Table 101. Cytokinetics, Inc. Product
Table 102. Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 103. Cytokinetics, Inc. Recent Development
Table 104. Merck & Co. Company Details
Table 105. Merck & Co. Business Overview
Table 106. Merck & Co. Product
Table 107. Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck & Co. Recent Development
Table 109. Novartis AG Company Details
Table 110. Novartis AG Business Overview
Table 111. Novartis AG Product
Table 112. Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 113. Novartis AG Recent Development
Table 114. Orion Corporation Business Overview
Table 115. Orion Corporation Product
Table 116. Orion Corporation Company Details
Table 117. Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 118. Orion Corporation Recent Development
Table 119. PhaseBio Pharmaceuticals, Inc Company Details
Table 120. PhaseBio Pharmaceuticals, Inc Business Overview
Table 121. PhaseBio Pharmaceuticals, Inc Product
Table 122. PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020) (Million US$)
Table 123. PhaseBio Pharmaceuticals, Inc Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Heart Failure (AHF) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. B-Blockers Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Cardiac Glycosides Features
Figure 5. Diuretics Features
Figure 6. Morphine Features
Figure 7. Vasodilators/Nitrates Features
Figure 8. Others Features
Figure 9. Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Home Care Case Studies
Figure 13. Acute Heart Failure (AHF) Therapeutics Report Years Considered
Figure 14. Global Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players in 2019
Figure 19. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Acute Heart Failure (AHF) Therapeutics Revenue in 2019
Figure 21. North America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed

---